Global Erectile Dysfunction Drugs Market Growth 2025-2031

Publication ID:

LPI05250095

Publication Date:

May 1, 2025

Pages:

101

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Erectile Dysfunction Drugs market size is predicted to grow from US$ 6534 million in 2025 to US$ 9973 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share. The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
Market trends and future development
Market demand continues to grow: With the increase in ED prevalence and the younger patient population, the market demand for ED drugs will continue to grow.
New products and new dosage forms continue to emerge: In order to meet the diverse needs of patients, new pharmaceutical companies continue to develop new products and new dosage forms, such as orodisintegrating tablets and long-acting preparations.
Policy incentives and market access: The government's attention to men's health issues and the improvement of drug supervision and market access mechanisms will provide more development opportunities for the ED drug market.
New retail channels and digital marketing: With the rise of new retail channels and the popularization of digital marketing, the ED drug market will pay more attention to user experience and personalized services.
The 鈥淓rectile Dysfunction Drugs Industry Forecast鈥� looks at past sales and reviews total world Erectile Dysfunction Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Erectile Dysfunction Drugs sales for 2025 through 2031. With Erectile Dysfunction Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Erectile Dysfunction Drugs industry.
This Insight Report provides a comprehensive analysis of the global Erectile Dysfunction Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Erectile Dysfunction Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Erectile Dysfunction Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Erectile Dysfunction Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Erectile Dysfunction Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Erectile Dysfunction Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Sildenafil
Tadalafil
Others
Segmentation by Application:
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
CSBIO.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Erectile Dysfunction Drugs market?
What factors are driving Erectile Dysfunction Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Erectile Dysfunction Drugs market opportunities vary by end market size?
How does Erectile Dysfunction Drugs break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Erectile Dysfunction Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Erectile Dysfunction Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Erectile Dysfunction Drugs by Country/Region, 2020, 2024 & 2031
2.2 Erectile Dysfunction Drugs Segment by Type
2.2.1 Sildenafil
2.2.2 Tadalafil
2.2.3 Others
2.3 Erectile Dysfunction Drugs Sales by Type
2.3.1 Global Erectile Dysfunction Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Erectile Dysfunction Drugs Sale Price by Type (2020-2025)
2.4 Erectile Dysfunction Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Private Clinics
2.4.3 Retail Pharmacies
2.4.4 E-Commerce (B2B)
2.4.5 E-Commerce (B2C)
2.5 Erectile Dysfunction Drugs Sales by Application
2.5.1 Global Erectile Dysfunction Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Erectile Dysfunction Drugs Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Erectile Dysfunction Drugs Breakdown Data by Company
3.1.1 Global Erectile Dysfunction Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Erectile Dysfunction Drugs Sales Market Share by Company (2020-2025)
3.2 Global Erectile Dysfunction Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Erectile Dysfunction Drugs Revenue by Company (2020-2025)
3.2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Erectile Dysfunction Drugs Sale Price by Company
3.4 Key Manufacturers Erectile Dysfunction Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Erectile Dysfunction Drugs Product Location Distribution
3.4.2 Players Erectile Dysfunction Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Erectile Dysfunction Drugs by Geographic Region
4.1 World Historic Erectile Dysfunction Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Erectile Dysfunction Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Erectile Dysfunction Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Erectile Dysfunction Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Erectile Dysfunction Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Erectile Dysfunction Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Erectile Dysfunction Drugs Sales Growth
4.4 APAC Erectile Dysfunction Drugs Sales Growth
4.5 Europe Erectile Dysfunction Drugs Sales Growth
4.6 Middle East & Africa Erectile Dysfunction Drugs Sales Growth
5 Americas
5.1 Americas Erectile Dysfunction Drugs Sales by Country
5.1.1 Americas Erectile Dysfunction Drugs Sales by Country (2020-2025)
5.1.2 Americas Erectile Dysfunction Drugs Revenue by Country (2020-2025)
5.2 Americas Erectile Dysfunction Drugs Sales by Type (2020-2025)
5.3 Americas Erectile Dysfunction Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Erectile Dysfunction Drugs Sales by Region
6.1.1 APAC Erectile Dysfunction Drugs Sales by Region (2020-2025)
6.1.2 APAC Erectile Dysfunction Drugs Revenue by Region (2020-2025)
6.2 APAC Erectile Dysfunction Drugs Sales by Type (2020-2025)
6.3 APAC Erectile Dysfunction Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Erectile Dysfunction Drugs by Country
7.1.1 Europe Erectile Dysfunction Drugs Sales by Country (2020-2025)
7.1.2 Europe Erectile Dysfunction Drugs Revenue by Country (2020-2025)
7.2 Europe Erectile Dysfunction Drugs Sales by Type (2020-2025)
7.3 Europe Erectile Dysfunction Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Erectile Dysfunction Drugs by Country
8.1.1 Middle East & Africa Erectile Dysfunction Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Erectile Dysfunction Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Erectile Dysfunction Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Erectile Dysfunction Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Erectile Dysfunction Drugs
10.3 Manufacturing Process Analysis of Erectile Dysfunction Drugs
10.4 Industry Chain Structure of Erectile Dysfunction Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Erectile Dysfunction Drugs Distributors
11.3 Erectile Dysfunction Drugs Customer
12 World Forecast Review for Erectile Dysfunction Drugs by Geographic Region
12.1 Global Erectile Dysfunction Drugs Market Size Forecast by Region
12.1.1 Global Erectile Dysfunction Drugs Forecast by Region (2026-2031)
12.1.2 Global Erectile Dysfunction Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Erectile Dysfunction Drugs Forecast by Type (2026-2031)
12.7 Global Erectile Dysfunction Drugs Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Erectile Dysfunction Drugs Product Portfolios and Specifications
13.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Erectile Dysfunction Drugs Product Portfolios and Specifications
13.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Erectile Dysfunction Drugs Product Portfolios and Specifications
13.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 BaiYunShan General Factory
13.4.1 BaiYunShan General Factory Company Information
13.4.2 BaiYunShan General Factory Erectile Dysfunction Drugs Product Portfolios and Specifications
13.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BaiYunShan General Factory Main Business Overview
13.4.5 BaiYunShan General Factory Latest Developments
13.5 S.K. Chemicals
13.5.1 S.K. Chemicals Company Information
13.5.2 S.K. Chemicals Erectile Dysfunction Drugs Product Portfolios and Specifications
13.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 S.K. Chemicals Main Business Overview
13.5.5 S.K. Chemicals Latest Developments
13.6 Teva Pharma
13.6.1 Teva Pharma Company Information
13.6.2 Teva Pharma Erectile Dysfunction Drugs Product Portfolios and Specifications
13.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Pharma Main Business Overview
13.6.5 Teva Pharma Latest Developments
13.7 Dong-A ST
13.7.1 Dong-A ST Company Information
13.7.2 Dong-A ST Erectile Dysfunction Drugs Product Portfolios and Specifications
13.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dong-A ST Main Business Overview
13.7.5 Dong-A ST Latest Developments
13.8 Petros Pharmaceuticals
13.8.1 Petros Pharmaceuticals Company Information
13.8.2 Petros Pharmaceuticals Erectile Dysfunction Drugs Product Portfolios and Specifications
13.8.3 Petros Pharmaceuticals Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Petros Pharmaceuticals Main Business Overview
13.8.5 Petros Pharmaceuticals Latest Developments
13.9 Seoul Pharma
13.9.1 Seoul Pharma Company Information
13.9.2 Seoul Pharma Erectile Dysfunction Drugs Product Portfolios and Specifications
13.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Seoul Pharma Main Business Overview
13.9.5 Seoul Pharma Latest Developments
13.10 CSBIO.
13.10.1 CSBIO. Company Information
13.10.2 CSBIO. Erectile Dysfunction Drugs Product Portfolios and Specifications
13.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 CSBIO. Main Business Overview
13.10.5 CSBIO. Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂